The selectivity of ligands specific for certain cells can be used to preferentially target chemotherapeutic compounds to neoplastic cells. Human breast, ovarian, endometrial, and prostatic cancers express receptors that can mediate the delivery of targeted cytotoxic compounds to 
Chemotherapeutic analogs conjugated to cell-and tumorspecific ligands have been designed because of their potential to reduce the nonspecific toxic side-effects and to increase their efficacy on targeted tissues (1, 2) . The presence of luteinizing hormone-releasing hormone (LH-RH) receptors in breast, ovarian, and endometrial cancers, as well as in most prostate cancers, has led to synthesis of novel cytotoxic LH-RH analogs as potential targeted therapeutic agents (1) (2) (3) (4) (5) (6) . A potent derivative of the chemotherapeutic agent doxorubicin, 2-pyrrolinodoxorubicin (AN-201) (7) , conjugated to [DLys 6 ] LH-RH (8) , was demonstrated to be less toxic than nonconjugated chemotherapeutic radicals and significantly more active in slowing neoplastic cellular growth (6, 9) .
Recently, intracellular signaling mechanisms that induce apoptosis have been increasingly well characterized (10) (11) (12) . Although there are multiple points of apoptosis induction and downstream effectors, cytotoxicity and inducible cellular death ultimately rely on a central apoptotic pathway that involves the caspases proteolytic cascade in both nuclear DNA and cellular structural and regulatory proteins. Caspases are dynamically regulated by a net equilibrium of proapoptotic Bax and antiapoptotic Bcl-2 regulatory proteins. Bax may heterodimerize with Bcl-2 to competitively inhibit its action, and Bax homodimers can induce proapoptotic intracellular signaling pathways (12) . Therefore, stoichiometric ratios of these two effectors are critical in determining cell viability and apoptotic induction.
Thus we studied the effects of cytotoxic conjugate consisting of 2-pyrrolinodoxorubicin linked to [D-Lys 6 ] LH-RH (AN-207) by using mammalian COS cells that stably express recombinant human LH-RH receptor (LH-RH-Rc), and compared its effects to parental COS cells that do not express endogenous LH-RH-Rc. We examined nucleosome cleavage patterns in transfected and parental cell lines exposed to either unconjugated 2-pyrrolinodoxorubicin (AN-201) or AN-207. Steadystate levels of both Bax and Bcl-2, as well as overall cell proliferative rates, also were assessed for the two compounds in both cell lines. Our results indicate that stable cell lines expressing LH-RH-Rc are more sensitive to the cytotoxic effects of LH-RH conjugate AN-207 and that its apoptotic action is induced through the Bax͞Bcl-2 regulatory pathway.
MATERIALS AND METHODS
Generation of Stable COS Cell Lines with Inducible Human LH-RH-Rc Expression. COS-7 cells (American Type Culture Collection) were cultured in DMEM supplemented with 10% fetal calf serum (FCS), penicillin, and streptomycin (GIBCO͞ BRL) in 95% air͞5% CO 2 at 37°C. Recombinant human LH-RH-Rc cDNA (provided by Thomas Gudermann, Freie Univerisität, Berlin, Germany; ref. 13) with an N-terminal hemagglutinin (HA) tag was inserted into the HindIII͞NcoI site of pIND inducible expression vector (Invitrogen) to generate LH-RH-Rc͞pIND. Cells (2 ϫ 10 5 ͞well) then were cotransfected with LH-RH-Rc͞pIND and pVgRXR plasmids (ecdysone inducible expression system, Invitrogen), using Lipofectamine (GIBCO͞BRL) according to manufacturer's optimized protocol for COS cells. Stable COS cell clones were selected with zeocin (200 g͞ml) (Invitrogen) and neomycin (400 g͞ml) (GIBCO͞BRL). Several clonal cell lines were expanded from single foci and subsequently were screened by Western blotting for expression of HA-tagged LH-RH-Rc in the presence of the ecdysone analogs at indicated concentration for 24 h (Invitrogen).
Transient Transfection͞Functional Assays of Recombinant LH-RH-Rc. A human glycoprotein hormone ␣-subunit responsive reporter (␣-846 Luc͞paLuc, courtesy of J. L. Jameson, Northwestern University, Chicago) was transiently transfected (1 g͞well) in stable COS cell lines by using Lipofectamine according to manufacturer's protocol (GIBCO͞BRL). Ecdysone analog (10 M; Invitrogen) was added for 24 h to culture medium. [D-Lys 6 ] LH-RH and͞or LH-RH antagonist (Cetrorelix, ASTA Medica, Frankfurt Am-Main, Germany) then were added at the indicated concentrations to triplicate wells of transiently transfected cells. After 24 h, cells were lysed in 150 l of lysis buffer containing 1% Triton X-100, 10% glycerol, 2 mM EDTA, 2 mM DTT, and 25 mM Trisphosphate, pH 7.8. Luciferase activity was assayed in 100 l of cell lysate by using a luminometer (EG & G Berthold, Gaithersburg, MD) in the presence of D-luciferin (Molecular Probes) and ATP (Sigma).
DNA Fragmentation Assay. Stable COS cell lines were seeded in 6-well plates at 10 4 cells͞well and incubated for 24 h in the presence of 10 M ecdysone analog in 10% FCS͞ DMEM. AN-201, AN-207, both synthesized at Tulane University as described (7, 8) , and the LH-RH antagonist antide (Bachem) then were added to the medium at the indicated concentrations. After 72 h, cells were harvested and incubated with lysis buffer [20 mM EDTA͞10 mM Tris⅐HCl, pH 8.0͞ 0.5% SDS (Sigma)͞100 g͞ml Proteinase K (Boehringer Mannheim)] at 37°C for 1 h, followed by ribonuclease A (Promega) (100 g͞ml) digestion. Genomic DNA was extracted by phenol-chloroform protocol (Amresco, Solon, OH) and precipitated with 60% (vol͞vol) isoproterenol. DNA (2 g) was labeled with ␣[P
32
]dCTP by using 5 units of terminal deoxynucleotidyl transferase (Amersham Pharmacia) per sample for 90 min at 37°C as described (14) . Labeled DNA fragments were reprecipitated with 60% isoproterenol and resolved by using 10% PAGE, followed by autoradiography.
Immunoblotting Assay. Stable LH-RH-Rc COS cells were incubated for 36 h in the presence of 10 M ecdysone analog in 10% FCS͞DMEM, followed by administration of AN-201, AN-207, and͞or Cetrorelix to culture medium at the indicated concentrations for 1 h. Then cells were rinsed once with PBS and solubilized with buffer containing 25 mM Tris⅐HCl, 250 mM sodium chloride, 2 mM EDTA, 1% Triton X-100, and 10 g͞ml aprotinin (Sigma) on ice. The homogenates were centrifuged at 10,000 ϫ g for 15 min. Protein concentration in each sample was determined by Bradford assay (Sigma), and equal amounts of protein (70 g͞lane) were separated by 10% SDS͞PAGE. The resolved proteins were electroblotted onto poly(vinylidene difluoride) filters (Micron Separations) in transfer buffer (192 mM glycine͞20% methanol͞25 mM Tris⅐HCl). To reduce nonspecific binding, the filters were incubated in a blocking buffer (20 mM Tris, pH 7.6͞137 mM sodium chloride͞10% nonfat milk͞0.1% Tween-20) at 5°C overnight. Filters then were incubated with specific primary antibodies at indicated dilution for 1 h at room temperature, rinsed in wash buffer (Tris-buffered saline, pH 7.6, and 0.1% Tween-20) four times for 10 min each. Primary antibodies used were anti-Bax (1:2,000) and anti-Bcl-2 (1:1,000) rabbit polyclonal antibodies (Santa Cruz Biotechnology), as well as antiactin (1:2,000) and antihemagglutinin (1:500) mAb (Boehringer Mannheim). Secondary antibodies used were anti-rabbit (1:4,000) or anti-mouse (1:4,000) IgG conjugated with horseradish peroxidase (Boehringer Mannheim). Western blots were visualized by enhanced chemiluminescence (Boehringer Mannheim).
Cell Proliferation Assay. The Cell Titer 96AQueous One solution cell proliferation assay (Promega) was used to assess the number of viable cells after AN-201 and AN-207 administration. Cells were plated in 6-well plates at 5,000 cells͞well in 10% FCS͞DMEM and treated with 10 M ecdysone analog for 36 h. AN-201, AN-207, and LH-RH antagonist Cetrorelix were added in the indicated dosages to triplicate wells for 1 h in the presence of ecdysone analog at 10 M concentration. The cells were washed twice with PBS and were cultured further in 10% FCS͞DMEM medium. Cell Titer 96AQueous One solution was added to each well for 30 min, and the light absorbance at 490 nm was recorded by using a spectrophotometer as a direct measurement of cell viability. Cell viability data at 72 h are presented as the mean Ϯ SD of triplicate wells. Statistical significance was tested by Student's t test by using SIGMAPLOT, version 3.06, Jandel Software.
RESULTS

Characterization of Stable COS Cell Lines Expressing
Human Recombinant LH-RH-Rc. Stable COS cell lines harboring recombinant LH-RH-Rc first were functionally tested for inducible expression by the ability of the receptor to up-regulate a human glycoprotein hormone ␣-subunit promoter͞luciferase (␣SU͞Luc) reporter fusion gene. Fig. 1 shows Western blots demonstrating inducibility of recombinant LH-RH-Rc protein expression in response to ecdysone analog, with maximal stimulation at a concentration of 10 M. After 72 h, cells were harvested and incubated with lysis buffer at 37°C for 1 h, followed by ribonuclease A digestion. [␣-32 P]dCTP-labeled genomic DNA fragments were isoproterenol-reprecipitated and resolved by using 10% PAGE, followed by autoradiography. 
DISCUSSION
The selectivity of ligands specific for certain cells can be used to preferentially target chemotherapeutic compounds to neoplastic cells (1) (2) (3) (4) (5) . Human breast, ovarian, endometrial, and prostatic cancers express receptors that can mediate the delivery of targeted cytotoxic compounds to neoplastic cells. Antineoplastic compounds conjugated to hormone derivatives may provide a viable approach to targeted chemotherapy. In this study we investigated the molecular mechanisms underlying the cytotoxic action of 2-pyrrolinodoxorubicin conju- Apoptosis is an integral biologic mechanism of many developmental and pathophysiologic states and reflects multiple biochemical events that ultimately lead to cell death via common mechanisms of cellular membrane perforation, chromatin condensation, DNA fragmentation, cell shrinkage, and disassembly into membrane-enclosed vesicles (apoptotic bodies) (10) . Apoptotic signaling varies from cell to cell, and different inducers may trigger distinct signaling pathways. Recent studies suggest that these pathways converge on selfdestruction mechanisms that are in part modulated by a net equilibrium of proapoptotic Bax and antiapoptotic Bcl-2 regulatory proteins (12) . Repression or down-regulation of steady-state protein levels of the antiapoptotic Bcl-2 with concurrent increases in Bax levels is a common mechanism for apoptotic induction. Bcl-2 homodimers prevent the apoptosis signaling cascade whereas Bax heterodimerizes with death antagonists such as Bcl-2 and Bcl-x L . Bax homodimers trigger apoptotic signaling at multiple levels. This ratio of Bcl-2 family death agonists to antagonists dictates the susceptibility of cells to an apoptotic stimulus (12) . Caspase 3 activity can be induced by proapoptotic Bax and inhibited by the antiapoptotic Bcl-2. Activation of caspase family enzymes results in cleavage of cytoskeletal and nuclear proteins, and nucleosomal fragmentation of DNA (14) . Convergent events in apoptosis center on mitochondria. Release of caspase activators, such as cytochrome c, changes in electron transport, loss of mitochondrial transmembrane potential, altered cellular oxidationreduction, and participation of Bcl-2 family proteins lead to apoptosis (11) . However, other studies have shown that inhibiting caspases does not always reduce cell death induced by Bcl-2 proapoptotic markers (18, 19) .
Thus, these data are consistent with increased apoptotic induction by AN-207 in cells that synthesize recombinant LH-RH-Rc. This model system may be useful in future studies examining the pharmacology and efficacy of novel LH-RH conjugated analogues, as well as the ability of LH-RH antagonists such as Cetrorelix to block the apoptotic effects of such conjugates. In addition, because the LH-RH-Rc is expressed by using an inducible vector system, cell lines can be manipulated to test the apoptotic effect of conjugates as a function of receptor density, which may be considered when designing targeted cytotoxic analogs. , and LH-RH antagonist Cetrorelix were added in the indicated doses to triplicate wells for 1 h. Cells were washed twice with PBS and were cultured further in 10% FCS͞DMEM medium. Cell Titer 96AQueous One solution was added to each well for 30 min, and the light absorbance at 490 nm was recorded by using a spectrophotometer as a direct measurement of cell viability. Cell viability data at 72 h are presented as the mean Ϯ SD of triplicate wells. Statistical significance was tested by using Student's t test. ‫,ء‬ P Ͻ 0.0003; ‫,ءء‬ P Ͻ 0.002; ‫,ءءء‬ P Ͻ 0.00006, significant difference from the value of AN-207-treated LH-RH-Rc-expressing cells.
